The Stratio 'LinkSquare' is a portable spectroscope that enables users to perform drug identification techniques without having to rely on guesswork or comparisons to do so.
The Stratio 'LinkSquare' works by being connected with a pill in order to identify the drug in a matter of just seconds. The technology can be utilized by pharmacists, technicians or assistants in order to cut down the wait time for those filling prescriptions or during trials in the lab.
The Stratio 'LinkSquare' portable spectroscope can be connected to an accompanying smartphone app in order to see the detailed information that is captured by the device. The drug identification device is small in design and capable of being kept in a pocket or lab coat in order to make it quick to pull out and use.
Drug-Identifying Devices
The Stratio 'LinkSquare' Spectroscope Makes Drug Identification Quick
Trend Themes
1. Portable Drug Identifying Devices - There is an opportunity to design more portable and user-friendly drug identifying devices for use in pharmaceutical settings.
2. Integration of Smartphone Technology in Drug Identification - Incorporating smartphone technology in drug identifying devices is a promising area to explore for companies looking to provide quick and seamless drug identification processes.
3. Automation of Drug Identification - Developing automated drug identifying devices that can scan multiple pills at once can greatly reduce the time it takes to identify unknown medications.
Industry Implications
1. Pharmaceutical Industry - The pharmaceutical industry can benefit greatly from improved drug identifying devices which can streamline the prescription-filling process.
2. Medical Technology Industry - Developing innovative and portable drug identifying devices presents an opportunity for companies in the medical technology industry to provide cutting-edge solutions for healthcare providers.
3. Research and Development Industry - Investing in the research and development of portable, smartphone-integrated and automated drug identifying devices presents an opportunity to disrupt the way drug identification is performed in clinical trials and laboratory settings.